- Previous Close
287.65 - Open
293.75 - Bid 293.10 x --
- Ask 294.00 x --
- Day's Range
288.00 - 300.05 - 52 Week Range
275.65 - 506.75 - Volume
10,027 - Avg. Volume
38,026 - Market Cap (intraday)
9.7B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
24.08 - EPS (TTM)
12.17 - Earnings Date Nov 8, 2024 - Nov 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 23, 2012
- 1y Target Est
--
Sastasundar Ventures Limited operates a digital network of healthcare and portfolio management services in India. The company operates through Financial Services and Healthcare Network segments. It is involved in financing of loans; investment in shares and securities; provision of financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The company engages in activities for pathology and marketing of healthcare and OTC products through e-commerce portal; and provision of diagnostic services, including pathological/radiological investigation. In addition, the company engages in the supply chain of medicine and wellness products; operates RetailerShakti.com and RetailerShakti mobile app for medicine, wellness, and FMCG products; and supplies products to retail pharmacies and local stores. The company was formerly known as Microsec Financial Services Limited and changed its name to Sastasundar Ventures Limited in November 2016. Sastasundar Ventures Limited was incorporated in 1989 and is based in Kolkata, India.
www.sastasundarventures.com941
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: SASTASUNDR.NS
View MorePerformance Overview: SASTASUNDR.NS
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SASTASUNDR.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SASTASUNDR.NS
View MoreValuation Measures
Market Cap
9.23B
Enterprise Value
8.60B
Trailing P/E
23.64
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.71
Price/Book (mrq)
1.20
Enterprise Value/Revenue
0.63
Enterprise Value/EBITDA
3.82
Financial Highlights
Profitability and Income Statement
Profit Margin
2.79%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
13.86B
Net Income Avi to Common (ttm)
387.27M
Diluted EPS (ttm)
12.17
Balance Sheet and Cash Flow
Total Cash (mrq)
489.58M
Total Debt/Equity (mrq)
0.39%
Levered Free Cash Flow (ttm)
--